(1)
Amarante, I.; Faustino, C.; Mota, B.; Cascais, M.; Almeida, J.; Valentim, M. Full Recovery over One Year of the Overlap Syndrome Scleromyositis to Maintenance Therapy With Mycophenolate Mofetil and Rituximab, Which Relapsed Within 8 Months of Discontinuation. EJCRIM 2025, 12 (5). https://doi.org/10.12890/2025_005154.